Personality Traits, Stress, and Emotional Intelligence Associated with Central Serous Chorioretinopathy

10 January 2021 : Clinical Research

Anita Pusic Sesar^1ABCDEFG, Antonio Sesar^1ACDEF, Kajo Bucan^2DFG, Irena Sesar^1ADG, Katarina Cvitkovic^1BCFG, Ivan Cavar^3ACDEF*

DOI: 10.12659/MSM.928677

Med Sci Monit 2021; 27:e928677

Table 2 Presence of systemic risk factors in the CSCR and control group.

Systemic risk factor	Presence	CSCR* group (N=57)	Control group (N=57)	P**	OR*** (95%: CI)
Hypertension	Yes	12	11	0.815	1.115 (0.446–2.786)
Hypertension	No	45	46	0.815	1.115 (0.446–2.786)
Autoimmune disease	Yes	5	1	0.093	5.385 (0.609–47.632)
Autoimmune disease	No	52	56	0.093	5.385 (0.609–47.632)
Use of steroids	Yes	3	0	0.079	–
Use of steroids	No	54	57	0.079	–
Gastroesophageal reflux	Yes	2	1	0.558	2.036 (0.179–23.110)
Gastroesophageal reflux	No	55	56	0.558	2.036 (0.179–23.110)
Pregnancy	Yes	2	0	0.154	–
Pregnancy	No	55	57	0.154	–
Sleep disturbances^#	Yes	21	18	0.554	1.264 (0.582–2.745)
Sleep disturbances^#	No	36	39	0.554	1.264 (0.582–2.745)
Use of psycho-pharmacologic drugs^##	Yes	2	0	0.154	–
Use of psycho-pharmacologic drugs^##	No	55	57	0.154	–
^* Central serous chorioretinopathy; ^ Chi square test; ^* odds ratio (confidence interval); ^# poor sleep quality and obstructive sleep apnea; ^## anxiolytic and antidepressant medications.